| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |